Welcome to our dedicated page for ArrowMark Financial SEC filings (Ticker: BANX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for ArrowMark Financial Corp. (NASDAQ: BANX), an SEC-registered, non-diversified, closed-end management investment company. Through these filings, investors can review how the fund describes its investment objective of providing current income, and to a lesser extent capital appreciation, and how it pursues this objective by investing primarily in regulatory capital securities of financial institutions.
Key documents available through the SEC’s EDGAR system include the fund’s Annual Reports and Semi-Annual Reports, which discuss portfolio composition, risk factors, and financial statements, as well as registration statements and prospectus materials that outline investment objectives, strategies, charges and expenses. ArrowMark Financial emphasizes that investors should consider these documents carefully, as there is no assurance the fund will achieve its investment objective and its shares may not be appropriate for all investors.
Current and historical Forms 10-K and 10-Q or N-CSR and N-CSRS equivalents for registered funds, along with Forms 8-K, detail material events such as distribution agreements and capital-raising transactions. For example, an 8-K filing describes a distribution agreement and related sub-placement agent agreement for at-the-market offerings of common stock under an effective registration statement and prospectus supplement.
On Stock Titan, BANX’s filings are paired with AI-powered summaries that explain the purpose and key points of each document in clear language. Real-time updates from EDGAR help users see new filings as they are posted, while AI highlights important disclosures related to risk factors, leverage, non-diversification, and the fund’s focus on regulatory capital securities. Users can quickly locate offering documents, material event reports and periodic filings to better understand ArrowMark Financial’s structure and risk profile.
ArrowMark Financial Corp. is conducting a transferable rights offering for up to 2,604,156 new common shares of BANX. Shareholders of record at 5:00 p.m. Eastern on January 22, 2026 receive one Right for each existing share and can buy one new share for every three Rights (a 1‑for‑3 offer), with an over‑subscription privilege for those who fully exercise.
The Subscription Price will be set at 92.5% of the average market price over the Expiration Date plus the prior four trading days, but not below 90% of NAV. Based on an estimated price of $19.93, the Fund projects gross proceeds of about $51.9 million and net proceeds of roughly $49.3 million after a $0.75 per‑share (3.75%) sales load and other offering costs.
The Fund plans to invest proceeds in its banking‑related strategy, including regulatory capital relief securities, and may temporarily pay down its credit facility. If fully subscribed at the estimated price, management estimates NAV per share would decline by about $0.76, or 3.5%, and non‑participating holders would experience ownership dilution, though Rights will trade on NASDAQ under “BANXR”, allowing holders to sell them.
ArrowMark Colorado Holdings, LLC filed a Schedule 13G reporting a significant ownership position in ArrowMark Financial Corp. common stock. As of 12/31/2025, the firm beneficially owned 808,076 shares, representing 10.35% of the outstanding common stock.
The reporting person, classified as an investment adviser, has sole voting and sole dispositive power over all 808,076 shares, with no shared voting or dispositive power. The filer certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of ArrowMark Financial Corp.
ArrowMark Financial Corp. entered into a new equity distribution agreement that allows it to issue and sell up to $25,000,000 of its common stock in at-the-market transactions. The company appointed ALPS Distributors, Inc. as its agent for these sales, and ALPS has a sub-placement agent agreement with UBS Securities LLC to help place the shares.
The shares will be sold under an existing Form N-2/A registration statement, using a base prospectus dated February 18, 2025 and a prospectus supplement dated December 15, 2025. ArrowMark filed the distribution and sub-placement agreements, along with a legal opinion from Troutman Pepper Locke LLP and a press release announcing the pricing of the offering, as exhibits to this report.
ArrowMark Financial Corp. plans an at-the-market offering of up to $25,000,000 of common stock, sold from time to time through ALPS Distributors under a distribution agreement. Shares will only be issued at or above the then-current net asset value per share plus the selling commission, so the company cannot sell new stock below NAV.
ArrowMark is a non-diversified, closed-end fund focused on current income from banking-related securities, especially regulatory capital relief instruments, preferred and subordinated debt, and CLO interests tied to banks and other financial institutions. It uses leverage via a credit facility and generally targets borrowings of about 30% of Managed Assets, with a management fee of 1.75% of Managed Assets paid to its adviser.
For the current fiscal year, total annual expenses are estimated at 7.40% of net assets, reflecting management fees, interest on borrowings and other operating costs. The distributor will receive a 1.00% commission on gross proceeds from ATM sales, with a portion payable to UBS Securities as sub-placement agent. Net proceeds are expected to be invested in line with the fund’s income-focused banking strategy within roughly three months after completion of the offering.
Melissa Marano Thompson filed an Initial Form 3 reporting her relationship to ArrowMark Financial Corp. (BANX) as a Director. The event date triggering the filing was 09/12/2025. The filing states that no securities are beneficially owned by the reporting person as of the report. The form lists her business address at ArrowMark Financial Corp., 100 Fillmore Street, Suite 325, Denver, CO 80206. The filing is an individual submission (Form filed by One Reporting Person) and is signed by Melissa Marano Thompson on 09/30/2025. This document discloses appointment and confirms the reporting person does not currently hold direct or indirect ownership of the issuer's equity securities.
ArrowMark Financial Corp., a NASDAQ-listed closed-end fund, focuses on generating current income mainly from regulatory capital relief securities, which made up 83% of total assets as of 6/30/2025. Total gross assets were $224 million, with approximately 83% of holdings in floating-rate assets, positioning the fund for elevated interest rate environments.
The fund reported a 10.0% historical distribution rate based on the last four quarters, and Q2 2025 EPS of $0.57 exceeded the declared distribution of $0.45 per share. Q2 2025 portfolio investment yield was 13.2%. Net asset value per share was $22.22 versus a market price of $20.93, a 5.8% discount. Over 1, 3, 5 and 10 years, total returns based on NAV were 13.99%, 13.71%, 12.21% and 9.25%.
The fund uses leverage, with a $64.5 million revolving credit facility outstanding as of 6/30/2025. Management highlights low historical correlation of NAV to major asset classes and emphasizes risks including credit, leverage, interest rate, regulatory and concentration in the banking and financial sectors.
FAQ
What is the current stock price of ArrowMark Financial (BANX)?
What is the market cap of ArrowMark Financial (BANX)?
